-
【GE CHENG News】Huadong Medicine sued Jolly Pharmaceutical again after its failure of the first instance, the Supreme People's Court has accepted the case
2026-05-07Huadong Medicine continued to appealed after losing the first instance. On the evening of February 26, according to the announcement of Jolly Pharmaceutical that due to the patent dispute involving Bailin, the plaintiff, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd had formally appealed to the -
【GE CHENG News】China and Austria extend PPH Pilot Program
2026-05-06According to a joint decision by the China National Intellectual Property Administration (CNIPA) and the Austrian Patent Office (ÖPA), the China–Austria Patent Prosecution Highway (PPH) pilot program will be extended for another five years, from March 1, 2026, to February 28, 2031. The requirements -
【GE CHENG News】In-depth analysis | From Germany to South Korea: Decoding the strategic intent behind Tulip Patent Pool's escalation of litigation against China
2026-03-17On January 26, 2026, Tulip Innovation Kft. announced that its patent infringement investigation targeting Chinese battery manufacturer Sunwoda and its client Geely Auto Group, initiated in South Korea, has been formally accepted by the Korea Trade Commission (KTC), showing Tulip patent pools expansi -
【GE CHENG News】2025 Research Report on Overseas Patent Data in China’s Automotive Industry
2026-03-17From 2021 to 2025, the number of overseas patent publications in Chinas automotive industry increased by 94.82%, reaching a total of 21,200. In terms of technological composition, new energy vehicles and intelligent connected vehicles accounted for more than 80% of the total. Among them, power batte -
【GE CHENG News】SCIO held a press conference to introduce the progress of intellectual property work in 2025
2026-03-17Intellectual property data overview1. PatentsIn 2025, a total of 972,000 invention patents were granted, along with 1.461 million utility model patents and 666,000 design patents. A total of 96,000 patent re-examinations and invalidation cases were concluded. The examination period for invention pat